Experimental strategies to reverse chronic renal disease

Michael Zeisberg, Raghu Kalluri

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Progression of chronic nephropathies still represents a major challenge for clinical nephrologists. Specific therapies that prevent patients from requiring dialysis or transplantation are still not available. However, recent experimental studies have demonstrated that regression of advanced lesions in the kidney can be achieved. This review summarizes the recent therapeutic advances using experimental models that might translate into novel human therapies to prevent, or significantly delay, requirement of renal replacement therapy.

Original languageEnglish (US)
Pages (from-to)440-445
Number of pages6
JournalBlood Purification
Volume22
Issue number5
DOIs
StatePublished - 2004
Externally publishedYes

Keywords

  • Bone morphogenic protein-7
  • Chronic renal injury reversal
  • Hepatocyte growth factor
  • Renal replacement therapy
  • Renin-angiotensin system
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Fingerprint

Dive into the research topics of 'Experimental strategies to reverse chronic renal disease'. Together they form a unique fingerprint.

Cite this